**Core Concept**
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by inflammation and destruction of joints. In addition to its effects on the musculoskeletal system, RA can also impact other organs, including the lungs. The disease process involves a complex interplay between immune cells, inflammatory cytokines, and tissue damage.

**Why the Correct Answer is Right**
RA can lead to lung involvement through several mechanisms. The inflammatory cytokines released in RA, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1), can cause inflammation and damage to lung tissue. This can result in the development of interstitial lung disease (ILD), characterized by fibrosis and scarring of lung tissue. Additionally, RA can increase the risk of pulmonary nodules, pleural effusions, and pulmonary embolism.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the effects of RA on the lung. While RA can cause systemic inflammation, it is not primarily associated with the development of systemic vasculitis.
**Option B:** This option is incorrect because it is too broad and does not specifically address the effects of RA on the lung. RA can cause a wide range of systemic symptoms, but lung involvement is a specific and important aspect of the disease.
**Option C:** This option is incorrect because it is not a recognized complication of RA. While RA can increase the risk of various comorbidities, lung cancer is not a well-established association.

**Clinical Pearl / High-Yield Fact**
RA patients are at increased risk of developing interstitial lung disease (ILD), which can be a significant cause of morbidity and mortality in these patients. ILD is a common cause of pulmonary symptoms and should be considered in the differential diagnosis of RA patients with respiratory complaints.

**Correct Answer: C. Interstitial lung disease (ILD) is a recognized complication of rheumatoid arthritis.**